2018
DOI: 10.1371/journal.pone.0198937
|View full text |Cite
|
Sign up to set email alerts
|

Supervised learning reveals circulating biomarker levels diagnostic of hepatocellular carcinoma in a clinically relevant model of non-alcoholic steatohepatitis; An OAD to NASH

Abstract: Although cirrhosis is a key risk factor for the development of hepatocellular carcinoma (HCC), mounting evidence indicates that in a subset of patients presenting with non-alcoholic steatohepatitis (NASH) HCC manifests in the absence of cirrhosis. Given the sheer size of the ongoing non-alcoholic fatty liver disease (NAFLD) epidemic and the dismal prognosis associated with late-stage primary liver cancer there is an urgent need for HCC surveillance in the NASH population. Using serum levels of HCC biomarkers a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

4
40
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
5
1

Relationship

2
4

Authors

Journals

citations
Cited by 17 publications
(44 citation statements)
references
References 33 publications
4
40
0
Order By: Relevance
“…The NAFLD spectrum starts with simple steatosis or lipid deposition within the liver. Left untreated, steatosis can progress to nonalcoholic steatohepatitis (NASH), i.e., steatosis accompanied by inflammation of the liver, NASH with fibrosis, cirrhosis and finally hepatocellular carcinoma (HCC) [ 3 , 4 , 5 , 6 , 7 , 8 ]. Considering that ~30% of the population in the United States alone has some steatosis, the risk for a NASH epidemic looms large [ 1 ].…”
Section: Introductionmentioning
confidence: 99%
See 4 more Smart Citations
“…The NAFLD spectrum starts with simple steatosis or lipid deposition within the liver. Left untreated, steatosis can progress to nonalcoholic steatohepatitis (NASH), i.e., steatosis accompanied by inflammation of the liver, NASH with fibrosis, cirrhosis and finally hepatocellular carcinoma (HCC) [ 3 , 4 , 5 , 6 , 7 , 8 ]. Considering that ~30% of the population in the United States alone has some steatosis, the risk for a NASH epidemic looms large [ 1 ].…”
Section: Introductionmentioning
confidence: 99%
“…Considering that ~30% of the population in the United States alone has some steatosis, the risk for a NASH epidemic looms large [ 1 ]. In fact, it is estimated that NAFLD-related hepatic complications will emerge as the leading cause of liver transplantation in the United States over the next 2 or 3 decades [ 1 , 2 , 3 ].…”
Section: Introductionmentioning
confidence: 99%
See 3 more Smart Citations